DVA vs LMAT · P/E 14, rev $12.82B vs P/E 35, rev $219.9M
DaVita HealthCare Partners Inc (DVA) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the DVA and LMAT stock pages for the full models.
Not investment advice.